Natural Astaxanthin Detected in the Iris/Ciliary Body of the Eye

Natural Astaxanthin Detected in the Iris/Ciliary Body of the Eye In a new study, natural astaxanthin extract (AstaREAL®) derived from Haematococcus microalgae was detected in the iris/ciliary body of New Zealand Albino (NZW) Rabbit Eyes 24 hours after ingestion.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Study Indicates Frankincense Provides Relief for Osteoarthritis PL Thomas, in alliance with Laila Nutra, India, has announced the publication of an article in BMJ's December 17 issue titled Frankincense: Systematic Review, in which the patent-pending Boswellia serrata extract 5-LOXIN was included. The article's objective was to assess evidence from randomized clinical trials about the effectiveness of extracts of Boswellia serrata (frankincense). Study Indicates Frankincense Provides Relief for Osteoarthritis PL Thomas, in alliance with Laila Nutra, India, has announced the publication of an article in BMJ's December 17 issue titled Frankincense: Systematic Review, in which the patent-pending Boswellia serrata extract 5-LOXIN was included. The article's objective was to assess evidence from randomized clinical trials about the effectiveness of extracts of Boswellia serrata (frankincense). Study Indicates Frankincense Provides Relief for Osteoarthritis PL Thomas, in alliance with Laila Nutra, India, has announced the publication of an article in BMJ's December 17 issue titled Frankincense: Systematic Review, in which the patent-pending Boswellia serrata extract 5-LOXIN was included. The article's objective was to assess evidence from randomized clinical trials about the effectiveness of extracts of Boswellia serrata (frankincense). Landmark Nutrigenomic Study Suggests That 'Sun Chlorella A' Helps Promote Overall Health Through Influencing Gene Expression A small nutrigenomic open label pilot study, published in the Journal of Medicinal Food, tested whole food supplement "Sun Chlorella A" and the impact on gene expression. The study suggests that Sun Chlorella influenced gene expression related to cholesterol and blood glucose. Landmark Nutrigenomic Study Suggests That 'Sun Chlorella A' Helps Promote Overall Health Through Influencing Gene Expression A small nutrigenomic open label pilot study, published in the Journal of Medicinal Food, tested whole food supplement "Sun Chlorella A" and the impact on gene expression. The study suggests that Sun Chlorella influenced gene expression related to cholesterol and blood glucose. Landmark Nutrigenomic Study Suggests That 'Sun Chlorella A' Helps Promote Overall Health Through Influencing Gene Expression A small nutrigenomic open label pilot study, published in the Journal of Medicinal Food, tested whole food supplement "Sun Chlorella A" and the impact on gene expression. The study suggests that Sun Chlorella influenced gene expression related to cholesterol and blood glucose. Hyabest® (J) - Recent Research supports efficacy for Knee Osteoarthritis Q.P. Corporation has developed an innovative hyaluronic acid specially designed for those with knee osteoarthritis - HyabestⓇ(J). For this product, they recently obtained 8-week clinical data based on a WOMAC randomized double-blind placebo-controlled clinical trial, which followed a successful result obtained earlier from a similar trial in Japan (JKOM). Hyabest® (J) - Recent Research supports efficacy for Knee Osteoarthritis Q.P. Corporation has developed an innovative hyaluronic acid specially designed for those with knee osteoarthritis - HyabestⓇ(J). For this product, they recently obtained 8-week clinical data based on a WOMAC randomized double-blind placebo-controlled clinical trial, which followed a successful result obtained earlier from a similar trial in Japan (JKOM). Hyabest® (J) - Recent Research supports efficacy for Knee Osteoarthritis Q.P. Corporation has developed an innovative hyaluronic acid specially designed for those with knee osteoarthritis - HyabestⓇ(J). For this product, they recently obtained 8-week clinical data based on a WOMAC randomized double-blind placebo-controlled clinical trial, which followed a successful result obtained earlier from a similar trial in Japan (JKOM). Hyabest® (J) - Recent Research supports efficacy for Knee Osteoarthritis Q.P. Corporation has developed an innovative hyaluronic acid specially designed for those with knee osteoarthritis - HyabestⓇ(J). For this product, they recently obtained 8-week clinical data based on a WOMAC randomized double-blind placebo-controlled clinical trial, which followed a successful result obtained earlier from a similar trial in Japan (JKOM). FDA Announces Permanent Injunction Against Wilderness Family Naturals LLC The U.S. Food and Drug Administration today announced that Wilderness Family Naturals LLC of Silver Bay, Minn., and its owners have signed a consent decree that prohibits them from manufacturing and distributing any products with unapproved claims that the products cure, treat, mitigate or prevent diseases. FDA Announces Permanent Injunction Against Wilderness Family Naturals LLC The U.S. Food and Drug Administration today announced that Wilderness Family Naturals LLC of Silver Bay, Minn., and its owners have signed a consent decree that prohibits them from manufacturing and distributing any products with unapproved claims that the products cure, treat, mitigate or prevent diseases. FDA Announces Permanent Injunction Against Wilderness Family Naturals LLC The U.S. Food and Drug Administration today announced that Wilderness Family Naturals LLC of Silver Bay, Minn., and its owners have signed a consent decree that prohibits them from manufacturing and distributing any products with unapproved claims that the products cure, treat, mitigate or prevent diseases. NPA Notes Limitations of JNCI Study on Vitamin C and E on Cancer Incidence in Women A new study published Tuesday, December 30, in The Journal of the National Cancer Institute (JNCI), suggests that long-term dietary supplementation with any combination of the antioxidants vitamin C, vitamin E, or beta carotene does not reduce the risk of cancer or the risk of dying from cancer in women already at an elevated risk for cardiovascular disease. NPA Notes Limitations of JNCI Study on Vitamin C and E on Cancer Incidence in Women A new study published Tuesday, December 30, in The Journal of the National Cancer Institute (JNCI), suggests that long-term dietary supplementation with any combination of the antioxidants vitamin C, vitamin E, or beta carotene does not reduce the risk of cancer or the risk of dying from cancer in women already at an elevated risk for cardiovascular disease. NPA Notes Limitations of JNCI Study on Vitamin C and E on Cancer Incidence in Women A new study published Tuesday, December 30, in The Journal of the National Cancer Institute (JNCI), suggests that long-term dietary supplementation with any combination of the antioxidants vitamin C, vitamin E, or beta carotene does not reduce the risk of cancer or the risk of dying from cancer in women already at an elevated risk for cardiovascular disease. NPA Notes Limitations of JNCI Study on Vitamin C and E on Cancer Incidence in Women A new study published Tuesday, December 30, in The Journal of the National Cancer Institute (JNCI), suggests that long-term dietary supplementation with any combination of the antioxidants vitamin C, vitamin E, or beta carotene does not reduce the risk of cancer or the risk of dying from cancer in women already at an elevated risk for cardiovascular disease. Jedwards International is Now Certified EU Organic Under the EEC 2092.91. Jedwards has announced their newest EU certified organic oils, which include; Organic Borage Oil, Organic Grape Seed Oil, Organic Carnauba Wax and Organic Beeswax. Jedwards International is Now Certified EU Organic Under the EEC 2092.91. Jedwards has announced their newest EU certified organic oils, which include; Organic Borage Oil, Organic Grape Seed Oil, Organic Carnauba Wax and Organic Beeswax. Jedwards International is Now Certified EU Organic Under the EEC 2092.91. Jedwards has announced their newest EU certified organic oils, which include; Organic Borage Oil, Organic Grape Seed Oil, Organic Carnauba Wax and Organic Beeswax. Jedwards International is Now Certified EU Organic Under the EEC 2092.91. Jedwards has announced their newest EU certified organic oils, which include; Organic Borage Oil, Organic Grape Seed Oil, Organic Carnauba Wax and Organic Beeswax. Jedwards International is Now Certified EU Organic Under the EEC 2092.91. Jedwards has announced their newest EU certified organic oils, which include; Organic Borage Oil, Organic Grape Seed Oil, Organic Carnauba Wax and Organic Beeswax. Jedwards International is Now Certified EU Organic Under the EEC 2092.91. Jedwards has announced their newest EU certified organic oils, which include; Organic Borage Oil, Organic Grape Seed Oil, Organic Carnauba Wax and Organic Beeswax. Jedwards International is Now Certified EU Organic Under the EEC 2092.91. Jedwards has announced their newest EU certified organic oils, which include; Organic Borage Oil, Organic Grape Seed Oil, Organic Carnauba Wax and Organic Beeswax. Jedwards International is Now Certified EU Organic Under the EEC 2092.91. Jedwards has announced their newest EU certified organic oils, which include; Organic Borage Oil, Organic Grape Seed Oil, Organic Carnauba Wax and Organic Beeswax. Jedwards International is Now Certified EU Organic Under the EEC 2092.91. Jedwards has announced their newest EU certified organic oils, which include; Organic Borage Oil, Organic Grape Seed Oil, Organic Carnauba Wax and Organic Beeswax. Cran-Max Found Comparable to Antibiotics For UTI Treatment and Prevention A recent study published in the Journal of Antimicrobial Chemotherapy has shown that the administration of Cran-Max®, a proprietary cranberry concentrate, was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women. Cran-Max Found Comparable to Antibiotics For UTI Treatment and Prevention A recent study published in the Journal of Antimicrobial Chemotherapy has shown that the administration of Cran-Max®, a proprietary cranberry concentrate, was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women. Cran-Max Found Comparable to Antibiotics For UTI Treatment and Prevention A recent study published in the Journal of Antimicrobial Chemotherapy has shown that the administration of Cran-Max®, a proprietary cranberry concentrate, was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women. Cran-Max Found Comparable to Antibiotics For UTI Treatment and Prevention A recent study published in the Journal of Antimicrobial Chemotherapy has shown that the administration of Cran-Max®, a proprietary cranberry concentrate, was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women. Cran-Max Found Comparable to Antibiotics For UTI Treatment and Prevention A recent study published in the Journal of Antimicrobial Chemotherapy has shown that the administration of Cran-Max®, a proprietary cranberry concentrate, was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women. Cran-Max Found Comparable to Antibiotics For UTI Treatment and Prevention A recent study published in the Journal of Antimicrobial Chemotherapy has shown that the administration of Cran-Max®, a proprietary cranberry concentrate, was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women. Cran-Max Found Comparable to Antibiotics For UTI Treatment and Prevention A recent study published in the Journal of Antimicrobial Chemotherapy has shown that the administration of Cran-Max®, a proprietary cranberry concentrate, was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women. Cran-Max Found Comparable to Antibiotics For UTI Treatment and Prevention A recent study published in the Journal of Antimicrobial Chemotherapy has shown that the administration of Cran-Max®, a proprietary cranberry concentrate, was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women. Cran-Max Found Comparable to Antibiotics For UTI Treatment and Prevention A recent study published in the Journal of Antimicrobial Chemotherapy has shown that the administration of Cran-Max®, a proprietary cranberry concentrate, was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women. Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study). Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study). Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study). Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study). Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study). Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells. Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms. Even with Breast Cancer, Healthy Diet Counts Even with Breast Cancer, Healthy Diet Counts Even with Breast Cancer, Healthy Diet Counts Even with Breast Cancer, Healthy Diet Counts Even with Breast Cancer, Healthy Diet Counts Even with Breast Cancer, Healthy Diet Counts Even with Breast Cancer, Healthy Diet Counts Even with Breast Cancer, Healthy Diet Counts Want to Help Your Heart? Get a Good Night's Sleep Want to Help Your Heart? Get a Good Night's Sleep Want to Help Your Heart? Get a Good Night's Sleep Want to Help Your Heart? Get a Good Night's Sleep Want to Help Your Heart? Get a Good Night's Sleep Want to Help Your Heart? Get a Good Night's Sleep Want to Help Your Heart? Get a Good Night's Sleep Want to Help Your Heart? Get a Good Night's Sleep Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	In a new study, natural astaxanthin extract (AstaREAL®) derived from Haematococcus microalgae was detected in the iris/ciliary body of New Zealand Albino (NZW) Rabbit Eyes 24 hours after ingestion. Astaxanthin has been reported to have many benefits in the eye. Several human clinical studies reported the alleviation of eye fatigue (by improving accommodation function) in visual display terminal (VDT) workers after oral supplementation. However, up to now there has been no intraocular kinetic information available. In collaboration between the Ophthalmology Department of Kanazawa Medical University, Japan, and Fuji Chemical Industry, Japan, researchers investigated the ocular and blood serum levels of astaxanthin in 24 NZW albino rabbits. After administering a 100 mg/kg single oral dose, astaxanthin was determined by careful extraction followed by HPLC analysis over a period of 168 hours. According to the astaxanthin detection system, the time taken to reach maximum presence (Tmax) in serum and iris/ciliary body was 9 hours (at Cmax 61.3 ng/mL) and 24 hours (at Cmax 79.3) respectively. In other human studies with oral intake of astaxanthin, the Tmax in serum ranged between 9 and 12 hours. The intraocular penetration kinetics could have a similar pattern to humans but further study is necessary. This study adds to the growing body of science supporting astaxanthin’s benefits for eye fatigue caused by VDT use. AstaREAL is a registered trademark of Fuji Chemical Industry Co., Ltd. Fuji is the world leader in the production and research of natural astaxanthin with state of the art and fully enclosed cultivation facilities in Hawaii and Sweden. For information: contact@fujihealthscience.com References 2008 Fukuda et al., Intraocular penetration of astaxanthin in rabbit eyes. Atarashii Ganka, 25(10):1461-1464 (In Japanese). 2003 Odeberg et al., Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. Eur J Pharm Sci 19: 299-304.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software